{"title":"心理社会因素在评估支气管哮喘程度和有目的药物治疗中的重要性","authors":"J. Krynsky","doi":"10.11648/j.ijpc.20210706.12","DOIUrl":null,"url":null,"abstract":": The presented case is based on the work of auditing doctor of health insurance company based on data from general practitioners and specialist in pneumology asking for payment an expensive medication. The role of supervision is to access the necessity and justification of costly treatment or to draw the attention of physicians to critical situations of the client and their appropriate solution not only focusing on pharmacology. Monitoring lifelong treatment revealed several key points to significantly affect health that were not properly treated, and this led to disability and, more recently, high treatment costs at later date. The patient's main critical situations have been linked to stress and anxiety but apart from the isolated intervention of a general practitioner, this fact was no considered, not even by specialists. Bronchial asthma is an inflammatory process, and it is known that psychosocial factors play important role as initiators and modifying factors. Their action may affect measurable values of the disease, self-monitoring of the symptoms and adherence for therapy. Not only the pharmacotherapy, but psychological care and strengthening mental health also plays an important role to improve patient well-being. The patient should be viewed in a complex way and early appropriate intervention in risk factors may prevent loss of working potential and economic loss in costly medication.","PeriodicalId":14230,"journal":{"name":"International Journal of Pharmacy and Chemistry","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Importance of Psychosocial Factors in Evaluating the Degree of Bronchial Asthma and for Purposeful Pharmacotherapy\",\"authors\":\"J. Krynsky\",\"doi\":\"10.11648/j.ijpc.20210706.12\",\"DOIUrl\":null,\"url\":null,\"abstract\":\": The presented case is based on the work of auditing doctor of health insurance company based on data from general practitioners and specialist in pneumology asking for payment an expensive medication. The role of supervision is to access the necessity and justification of costly treatment or to draw the attention of physicians to critical situations of the client and their appropriate solution not only focusing on pharmacology. Monitoring lifelong treatment revealed several key points to significantly affect health that were not properly treated, and this led to disability and, more recently, high treatment costs at later date. The patient's main critical situations have been linked to stress and anxiety but apart from the isolated intervention of a general practitioner, this fact was no considered, not even by specialists. Bronchial asthma is an inflammatory process, and it is known that psychosocial factors play important role as initiators and modifying factors. Their action may affect measurable values of the disease, self-monitoring of the symptoms and adherence for therapy. Not only the pharmacotherapy, but psychological care and strengthening mental health also plays an important role to improve patient well-being. The patient should be viewed in a complex way and early appropriate intervention in risk factors may prevent loss of working potential and economic loss in costly medication.\",\"PeriodicalId\":14230,\"journal\":{\"name\":\"International Journal of Pharmacy and Chemistry\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Pharmacy and Chemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.11648/j.ijpc.20210706.12\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmacy and Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11648/j.ijpc.20210706.12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Importance of Psychosocial Factors in Evaluating the Degree of Bronchial Asthma and for Purposeful Pharmacotherapy
: The presented case is based on the work of auditing doctor of health insurance company based on data from general practitioners and specialist in pneumology asking for payment an expensive medication. The role of supervision is to access the necessity and justification of costly treatment or to draw the attention of physicians to critical situations of the client and their appropriate solution not only focusing on pharmacology. Monitoring lifelong treatment revealed several key points to significantly affect health that were not properly treated, and this led to disability and, more recently, high treatment costs at later date. The patient's main critical situations have been linked to stress and anxiety but apart from the isolated intervention of a general practitioner, this fact was no considered, not even by specialists. Bronchial asthma is an inflammatory process, and it is known that psychosocial factors play important role as initiators and modifying factors. Their action may affect measurable values of the disease, self-monitoring of the symptoms and adherence for therapy. Not only the pharmacotherapy, but psychological care and strengthening mental health also plays an important role to improve patient well-being. The patient should be viewed in a complex way and early appropriate intervention in risk factors may prevent loss of working potential and economic loss in costly medication.